Track topics on Twitter Track topics that are important to you
Invitae has acquired two diagnostics developers, CombiMatrix and Good Start Genetics, for a combined $72 million in cash and stock, in a deal designed to expand the buyer's diagnostics offerings across all stages of life, Invitae plans to shell out approximately $33 million for CombiMatrix focuses on diagnostics for prenatal diagnosis, miscarriage analysis and pediatric developmental disorders, while Good Start Genetics specializes in molecular diagnostics for preimplantation and carrier screening for inherited disorders. "This is a transformative moment for Invitae, for our industry, and—importantly—for patients,” Invitae CEO Sean George said in a statement yesterday. “By acquiring Good Start and CombiMatrix, Invitae intends to create the industry's first comprehensive genetic information platform providing high-quality, affordable genetic information coupled with world-class clinical expertise to inform healthcare decisions throughout every stage of an individual's life,” George said. Also yesterday, Invitae said separately it will sell $73.5 million of ...
Original Article: Invitae Acquires CombiMatrix, Good Start GeneticsNEXT ARTICLE
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...